Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers

Clinical trial NCT05451667 · COMPLETED

Trial details

NCT number: NCT05451667
Sponsor: Yuejia Pharmaceuticals (USA), Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety and Tolerability

Start date: 2022-08-15
Primary completion: 2022-12-20
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.